Option agreement for license to develop and commercialize new HIV/AIDS therapeutic.
D015704:CD4 Antigens / Q000627:therapeutic use*; D017277:Drug Approval; D004337:Drug Carriers; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D008081:Liposomes
D015704:CD4 Antigens; D004337:Drug Carriers; D008081:Liposomes